[Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa]
- PMID: 16477462
- DOI: 10.1007/s00106-005-1370-7
[Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa]
Abstract
Background: Long-term abuse of decongestive nasal drops causes rhinitis medicamentosa due to cytotoxic and ciliary-toxic effects. Nasal obstruction is caused by rebound swelling when the decongestive effect has disappeared. The patient starts using nasal drops more frequently as a result of tachyphylaxis.
Patients and methods: Tissue samples from human inferior turbinates from 22 patients who had overused decongestive nose drops were taken during nasal surgery and preserved in phosphate-buffered paraformaldehyde or glutaraldehyde. Ultrathin sections were cut. The samples were dehydrated and embedded in Araldit. The findings were photo-documented using a light- and transmission electron microscope. Biopsies from ten patients without chronic inflammation of the nasal mucosa were used as controls.
Results: The electron microscopic investigations revealed epithelium showing severe damage corresponding to regions with hyperplastic and metaplastic changes. Loss of ciliated cells was observed. Under a thick basal membrane, ultrastructural changes to the endothelial lining, such as openings and rupture of the basal lamina, were detected. Prominent endothelial cells were conspicuous.
Conclusions: Rhinitis medicamentosa is a drug-induced injury to human nasal mucosa associated with the prolonged abuse of topical nasal decongestants. Loss and destruction of ciliated epithelial cells are the morphological correlation to the disturbance of mucociliary clearance. Endothelial cells of capillaries, in particular, revealed ultrastructural changes indicative of increased permeability with consecutive interstitial edema.
Similar articles
-
Rhinitis medicamentosa: electron microscopic changes of human nasal mucosa.Otolaryngol Head Neck Surg. 2007 Jan;136(1):57-61. doi: 10.1016/j.otohns.2006.08.025. Otolaryngol Head Neck Surg. 2007. PMID: 17210334
-
Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.Rhinology. 1996 Mar;34(1):9-13. Rhinology. 1996. PMID: 8739860 Clinical Trial.
-
Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.Rhinology. 1995 Mar;33(1):14-7. Rhinology. 1995. PMID: 7540314
-
Rhinitis medicamentosa: what an otolaryngologist needs to know.Eur Arch Otorhinolaryngol. 2009 May;266(5):623-5. doi: 10.1007/s00405-008-0896-1. Epub 2008 Dec 19. Eur Arch Otorhinolaryngol. 2009. PMID: 19096862 Review.
-
Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.Eur Ann Otorhinolaryngol Head Neck Dis. 2013 Jun;130(3):137-44. doi: 10.1016/j.anorl.2012.09.005. Epub 2013 Feb 1. Eur Ann Otorhinolaryngol Head Neck Dis. 2013. PMID: 23375990 Review.
Cited by
-
[Immunocytochemical detection of caspase 3 in various diseases of human nasal mucosa].HNO. 2009 May;57(5):466-72. doi: 10.1007/s00106-009-1905-4. HNO. 2009. PMID: 19387597 German.
-
[New generation antihistamines as monotherapy or in combination. What is the relevance for daily clinical routine for allergic rhinoconjunctivitis].HNO. 2007 Jun;55(6):457-64. doi: 10.1007/s00106-006-1509-1. HNO. 2007. PMID: 17566806 Clinical Trial. German.
-
Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses.GMS Curr Top Otorhinolaryngol Head Neck Surg. 2010;9:Doc07. doi: 10.3205/cto000071. Epub 2011 Apr 27. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2010. PMID: 22073111 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical